RxDoctor Payments Data

Dina Irwin

Psychiatric/Mental Health · Sioux City, IANPI 1033890918

Payments from drug & device makers

$1,977in general payments, 2019–2025

Across 111 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$381
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$318
  • Otsuka America Pharmaceutical, Inc.$182
  • Vanda Pharmaceuticals Inc.$145
  • Lundbeck LLC$126
  • Alkermes, Inc.$102
  • plus $722 from 18 others

What the payments were for

  • Food & beverage$1,977100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,977 in reported general payments places this provider in the 70th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$10,708
Medicare patients
28
Services billed
192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole63$62,593
VraylarCariprazine Hcl27$37,669
SpravatoEsketamine Hcl27$26,585
LybalviOlanzapine/Samidorphan Malate11$17,930
Aripiprazole43$3,746
Divalproex Sodium ErDivalproex Sodium11$2,029
Fluoxetine Hcl66$1,372
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine29$1,328
Bupropion XlBupropion Hcl32$965
Venlafaxine Hcl ErVenlafaxine Hcl50$604
Olanzapine22$579
Quetiapine Fumarate76$551
Desvenlafaxine Succinate ErDesvenlafaxine Succinate15$544
Oxcarbazepine16$454
Prazosin Hcl31$424

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$182$62,59363 claims
AbbVieVraylar$381$37,66927 claims
Johnson & JohnsonSpravato$72$26,58527 claims
Alkermes, Inc.Lybalvi$102$17,93011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Sioux City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →